NDC 61958-1901

Genvoya

Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide

Genvoya is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Elvitegravir; Cobicistat; Emtricitabine; Tenofovir Alafenamide Fumarate.

• Product ID: 61958-1901_76c6837a-d214-4963-8749-0b9c533c4659
• NDC: 61958-1901
• Product Type: Human Prescription Drug
• Proprietary Name: Genvoya
• Generic Name: Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2015-11-05
• Marketing Category: NDA / NDA
• Application Number: NDA207561
• Labeler Name: Gilead Sciences, Inc.
• Substance Name: ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
• Active Ingredient Strength: 150 mg/1; mg/1; mg/1; mg/1
• Pharm Classes: HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61958-1901-1

30 TABLET in 1 BOTTLE, PLASTIC (61958-1901-1)

• Marketing Start Date: 2015-11-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61958-1901-1 [61958190101]

Genvoya TABLET

• Marketing Category: NDA
• Application Number: NDA207561
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-11-05

Drug Details

Active Ingredients

Ingredient	Strength
ELVITEGRAVIR	150 mg/1

OpenFDA Data

• SPL SET ID: 34784acf-15ed-4715-b504-eb30430518e9
• Manufacturer:
  • Gilead Sciences, Inc.
• UNII:
  • 4GDQ854U53
  • LW2E03M5PG
  • G70B4ETF4S
  • FWF6Q91TZO
• RxNorm Concept Unique ID - RxCUI:
  • 1721613
  • 1721619

Pharmacological Class

• HIV Integrase Inhibitors [MoA]
• Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
• Cytochrome P450 2C9 Inducers [MoA]
• Cytochrome P450 3A Inhibitors [MoA]
• Cytochrome P450 3A Inhibitor [EPC]
• P-Glycoprotein Inhibitors [MoA]
• Cytochrome P450 2D6 Inhibitors [MoA]
• Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
• Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
• Breast Cancer Resistance Protein Inhibitors [MoA]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• HIV Integrase Inhibitors [MoA]
• Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
• Cytochrome P450 2C9 Inducers [MoA]
• Cytochrome P450 3A Inhibitors [MoA]
• Cytochrome P450 3A Inhibitor [EPC]
• P-Glycoprotein Inhibitors [MoA]
• Cytochrome P450 2D6 Inhibitors [MoA]
• Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
• Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
• Breast Cancer Resistance Protein Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleosides [CS]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleosides [CS]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

Medicade Reported Pricing

61958190101 GENVOYA TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Genvoya" or generic name "Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide"

NDC	Brand Name	Generic Name
50090-2279	Genvoya	elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
61958-1901	Genvoya	elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
70518-0568	Genvoya	elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide